Venture startup

Who invested in Pionyr Immunotherapeutics

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$275Mraised across 1 round since 2020, from 1 source

Latest round
Venture, $275MJun 2020
Investors
4
See who backed them

The rounds

  1. Jun 2020

Everyone who backed them

OrbiMedPrivate equity1round
SV Health InvestorsVC firm1round
Mission BioCapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Pionyr Immunotherapeutics

Who invested in Pionyr Immunotherapeutics?

Pionyr Immunotherapeutics's investors include New Enterprise Associates, OrbiMed, SV Health Investors and Mission BioCapital.

How much has Pionyr Immunotherapeutics raised?

Pionyr Immunotherapeutics has raised $275M across 1 round since 2020.

When did Pionyr Immunotherapeutics last raise?

Pionyr Immunotherapeutics's most recent round was a Venture of $275M in Jun 2020.

What was Pionyr Immunotherapeutics's biggest round?

Its most recent round, $275M in Jun 2020, is also its largest on record.

Who backed Pionyr Immunotherapeutics first?

Pionyr Immunotherapeutics's first round on record, in Jun 2020, was backed by New Enterprise Associates, OrbiMed and SV Health Investors and 1 others.

What stage is Pionyr Immunotherapeutics at?

Pionyr Immunotherapeutics's latest named round is a Venture, in Jun 2020.

Companies like Pionyr Immunotherapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.